- URN to cite this document:
- urn:nbn:de:bvb:355-epub-508624
- DOI to cite this document:
- 10.5283/epub.50862
Abstract
Background Orthotopic liver transplantation (OLT) is the treatment option for early-stage hepatocellular carcinoma (HCC). OLT is often associated with high blood loss, requiring blood transfusion. Retransfusion of autologous blood is a key part of blood conservation. There are, however, concerns that the retransfusion of salvaged blood might cause the spread of cancer cells and induce ...
Owner only: item control page